Cerner launches SMART on FHIR coding platform

Cerner has launched the Cerner Open Developer Experience (code_) to enhance collaboration with third-party and client developers on SMART on FHIR applications.

code_ is a digital experience designed to meet market expectations of open communications, robust API documentation, provide clearly defined guidelines and access to tools that enable innovative app development.

“Cerner is committed to taking a leadership role to support third-party developers and help further health information technology,” said David McCallie, MD, senior vice president of Cerner's Medical Informatics. “Encouraging innovators to develop apps that work across existing health records can help the industry advance the way care is delivered through improved interoperability capabilities.”

Any developer can visit the new website to start coding with the SMART on FHIR tools in the Cerner open sandbox, research educational development tools and browse current apps that are available or in development. The site can be accessed from numerous different devices.

SMART on FHIR apps run on top of EHRs, allowing physicians to access the “pluggable apps” directly within their workflow to more easily visualize, interact and transmit health data, according to the company.

“Fostering new ideas from the developer community enables us to reach a broader market of potential users,” said Bob Robke, Cerner's vice president of interoperability. “It’s this open platform that has potential to unlock the next cutting-edge solution that could benefit not only our entire client base, but the industry as well.”

Fifteen new SMART on FHIR apps are in development or in production and will be showcased in Cerner's booth at the upcoming HIMSS Annual Conference & Exhibition.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.